335: Garnering Investor Recognition | Josh Blacher, CFO of Therapix Biosciences

CFO THOUGHT LEADER - Un pódcast de The Future of Finance is Listening

prueba podimo gratis durante 60 días!

Miles de audiolibros y podcasts exclusivos, haz clic aquí para probar

A brief summary of this episode